Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monother (Q34518606)
scientific article
Language:
Current Data About Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monother
(P31) (Q13442814)
(P248)
(P698) 16644631
(P813) Wednesday, August 2, 2017

(P50) (Q58689309)
(P1545) 13
(P1932) Ralph A DeFronzo
(P248)
(P698) 16644631
(P813) Wednesday, August 2, 2017

(P304) 1016-1023
(P248)
(P698) 16644631
(P813) Wednesday, August 2, 2017

(P407) (Q1860)

(P433) 5
(P248)
(P698) 16644631
(P813) Wednesday, August 2, 2017

(P478) 29
(P248)
(P698) 16644631
(P813) Wednesday, August 2, 2017

(P577) Monday, May 1, 2006
(P248)
(P698) 16644631
(P813) Wednesday, August 2, 2017

(P921) (Q3025883)

(Q181600)

(Q19484)
(P887)

(Q186319)
(P887)

(P1433) (Q5270111)
(P248)
(P698) 16644631
(P813) Wednesday, August 2, 2017

(P1476) "Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monother" (language: en)
(P248)
(P698) 16644631
(P813) Wednesday, August 2, 2017

"Improvement of Glycemic Control, Triglycerides, and HDL Cholesterol Levels With Muraglitazar, a Dual ( / ) Peroxisome Proliferator-Activated Receptor Activator, in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy: A do" (language: en)

(P2093) David M Kendall
(P1545) 1
(P248)
(P698) 16644631
(P813) Wednesday, August 2, 2017

Cindy J Rubin
(P1545) 2
(P248)
(P698) 16644631
(P813) Wednesday, August 2, 2017

Pharis Mohideen
(P1545) 3
(P248)
(P698) 16644631
(P813) Wednesday, August 2, 2017

Jean-Marie Ledeine
(P1545) 4
(P248)
(P698) 16644631
(P813) Wednesday, August 2, 2017

Rene Belder
(P1545) 5
(P248)
(P698) 16644631
(P813) Wednesday, August 2, 2017

Jorge Gross
(P1545) 6
(P248)
(P698) 16644631
(P813) Wednesday, August 2, 2017

Paul Norwood
(P1545) 7
(P248)
(P698) 16644631
(P813) Wednesday, August 2, 2017

Michael O'Mahony
(P1545) 8
(P248)
(P698) 16644631
(P813) Wednesday, August 2, 2017

Kenneth Sall
(P1545) 9
(P248)
(P698) 16644631
(P813) Wednesday, August 2, 2017

Greg Sloan
(P1545) 10
(P248)
(P698) 16644631
(P813) Wednesday, August 2, 2017

Anthony Roberts
(P1545) 11
(P248)
(P698) 16644631
(P813) Wednesday, August 2, 2017

Fred T Fiedorek
(P1545) 12
(P248)
(P698) 16644631
(P813) Wednesday, August 2, 2017

D. M. Kendall
(P1545) 1

other details
aliases Improvement of Glycemic Control, Triglycerides, and HDL Cholesterol Levels With Muraglitazar, a Dual ( / ) Peroxisome Proliferator-Activated Receptor Activator, in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy: A do
description scientific article

External Links
(P356) 10.2337/DC05-1146
10.2337/DIACARE.2951016
(P698) 16644631
(P5875) 277675493